BioCentury
ARTICLE | Company News

Affitech cancer, infectious, antibodies news

July 25, 2011 7:00 AM UTC

Affitech said shareholder Trans Nova Investments Ltd. sold 65 million of its Affitech shares to Krosalter Enterprises Ltd. Cyprus. Krosalter now owns 13% of Affitech, while Trans Nova now owns 195 mil...